Product Description
Mechanisms of Action: Contrast Agent
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Argentina | Austria | Brazil | Bulgaria | Canada | Colombia | Cyprus | Dominican Republic | Hungary | Iceland | India | Ireland | Italy | Korea | Lithuania | Malta | New Zealand | Peru | Portugal | Russia | Singapore | Slovenia | Sweden | Switzerland | Thailand | Turkey | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|